Company Overview - Marsh & McLennan Companies, Inc. (MMC) has a market cap of $91.6 billion and provides advisory services and insurance solutions focused on risk, strategy, and people, operating through its Risk and Insurance Services and Consulting segments [1] Financial Performance - Analysts forecast MMC to report an adjusted EPS of $1.97 for fiscal Q4 2025, representing a 5.4% increase from $1.87 in the same quarter last year [2] - For fiscal 2025, the expected adjusted EPS is $9.61, which is a 9.2% increase from $8.80 in fiscal 2024 [3] - Despite reporting a stronger-than-expected Q3 2025 adjusted EPS of $1.85 and revenue of $6.35 billion, shares of MMC fell 8.5% on October 16 due to flat operating margins and slowing growth in the risk and insurance segment [5] Market Performance - Over the past 52 weeks, shares of Marsh & McLennan have declined by 12.7%, underperforming the S&P 500 Index, which increased by 14.8%, and the State Street Financial Select Sector SPDR ETF, which returned 13.3% [4] Analyst Ratings - The consensus view on MMC stock is cautiously optimistic, with a "Moderate Buy" rating overall; among 25 analysts, there are seven "Strong Buy," one "Moderate Buy," 16 "Holds," and one "Moderate Sell" [6] - The average analyst price target for Marsh & McLennan is $211.28, indicating a potential upside of nearly 13% from current levels [6]

Core Viewpoint - Marsh & McLennan Companies, Inc. (MMC) has significantly underperformed the broader market and the insurance sector over the past year, despite reporting strong quarterly earnings that exceeded expectations [2][3][4]. Financial Performance - MMC's stock has declined 18.6% over the past year, while the S&P 500 Index has increased by nearly 13.7% [2]. - In Q3, MMC reported an adjusted EPS of $1.85, surpassing Wall Street's expectation of $1.79, and revenue of $6.4 billion, exceeding forecasts of $6.3 billion [4]. - Analysts project a 9.2% growth in EPS for the current fiscal year, expecting it to reach $9.61 on a diluted basis [4]. Analyst Ratings - Among 23 analysts covering MMC, the consensus rating is a "Moderate Buy," with five "Strong Buy" ratings, one "Moderate Buy," 16 "Holds," and one "Moderate Sell" [5]. - The overall rating has improved from a month ago, with one analyst suggesting a "Strong Sell" [6]. - TD Cowen analyst Andrew Kligerman maintained a "Hold" rating and lowered the price target to $200, indicating a potential upside of 10.6% from current levels [6]. Price Targets - The mean price target for MMC is $214.84, suggesting an 18.8% premium to current price levels [6]. - The highest price target of $258 indicates a potential upside of 42.6% [6].